Why the study?
Hypertension is a leading chronic disease and risk factor for cardiovascular mortality in China, yet awareness, treatment, and control rates remain low.
Population
Entire population, including healthy individuals, those susceptible to hypertension, and hypertensive patients
Design
National management guideline
Loading...
Adopts proactive hypertension management across all populations; extends prior standards with integrated screening, lifestyle, and treatment pathways for primary care.
This 2019 Chinese national guideline provides a standardized, comprehensive framework for hypertension prevention and management across the entire population.
A 2020 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: